LncRNA of peripheral blood mononuclear cells

Hymai acts as a potential diagnostic and therapeutic biomarker for female major depressive disorder

Bibliographic Data

ID15518524
AuthorsTianyi Bu (0000-0003-4134-8858, Harbin Medical University), Jiarun Yang (0000-0002-7879-3923, Heilongjiang University), Jiawei Zhou (0000-0003-4220-344X, Harbin Medical University), Y Liu (0000-0001-8420-6011, Harbin Medical University), Kexin Qiao (Harbin Medical University), Yan Wang (0009-0009-9633-0023, Harbin Medical University), Jili Zhang (0000-0002-0043-5106, Harbin Medical University), Erying Zhao (Harbin Medical University), Boakye Kwame Owura (Harbin Medical University), Xiaohui Qiu (0000-0001-9985-8231, Harbin Medical University, corresponding author), Zhengxue Qiao (0000-0002-4485-1443, Harbin Medical University, corresponding author), Yanjie Yang (0000-0002-8638-5313, Harbin Medical University, corresponding author)
Year2025
Volume16
Pages1241089-1241089
Publication date2025-02-27
Open AccessYes
TypeARTICLE
VenueFrontiers in Psychiatry (JOURNAL)
Journal identifiersISSN: 1664-0640 • E-ISSN: 1664-0640
PublisherFrontiers Media (PUBLISHER • CH)
DOI10.3389/fpsyt.2025.1241089
PMID40084057
OpenAlexW4408004892
LanguageEN
References cited74

Our findings showed that the dysregulated expression of lncRNA HYMAI may be the pathophysiological basis of women suffering from MDD. Here, insight into the molecular mechanism of women's susceptibility to MDD is shown. Meanwhile, a new perspective for future female MDD prevention, diagnosis and treatment, evaluation, detection, and intervention is provided

Biology · Biomarker · In vitro · Major depressive disorder · Mood · Peripheral · Peripheral blood · Peripheral blood mononuclear cell · Psychiatry · Cancer-related molecular mechanisms research · Circular RNAs in diseases · Dietary Effects on Health · Medicine · Genetics · Immunology · Internal Medicine

Tools

Open DOIOpen Access